Masimo (MASI)
(Delayed Data from NSDQ)
$108.09 USD
-0.90 (-0.83%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $108.05 -0.04 (-0.04%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MASI 108.09 -0.90(-0.83%)
Will MASI be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for MASI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MASI
West Pharmaceutical (WST) Misses on Q2 Earnings, Lowers '24 View
Thermo Fisher Scientific (TMO) Q2 Earnings and Revenues Top Estimates
MASI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Intuitive Surgical (ISRG) Q2 Earnings Beat, Procedures Robust
Reasons to Add Masimo (MASI) Stock to Your Portfolio Now
Masimo (MASI) Sues Politan for Misstatements, Delays Annual Meet
Other News for MASI
New Study Finds That Remote Patient Monitoring with Masimo SafetyNet? Significantly Reduced Rates of Hospital Readmission and ED Visits for Patients Recuperating at Home After Joint Replacement Surgery
Masimo: SafetyNet RPM reduces readmission and ED visits post surgery
Masimo to Report Second Quarter 2024 Financial Results After Market Close on Tuesday, August 6
3 Healthcare Stocks to Buy Now: Q3 Edition
Masimo Corporation: A Bitter Proxy Fight Hurts The Shares